Voyager Therapeutics
$4.699876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$4.69
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.16 (-3.39%) Today
+$0.13 (+2.85%) As of 8:57 PM UTC after-hours
Why Robinhood?
You can buy or sell VYGR and other stocks, options, and ETFs commission-free!
About VYGR
Voyager Therapeutics, Inc. Common Stock, also called Voyager Therapeutics, is a clinical-stage gene therapy company, which engages in the development of treatments for severe neurological diseases.
CEO
G. Andre Turenne
Employees
179
Headquarters
Cambridge, Massachusetts
Founded
2013
Market Cap
165.49M
Price-Earnings Ratio
4.87
Dividend Yield
—
Average Volume
452.15K
High Today
$4.75
Low Today
$4.49
Open Price
$4.75
Volume
355.51K
52 Week High
$14.62
52 Week Low
$4.45
Analyst Ratings
23%
of 13 ratings
Buy
23%
Hold
77%
Sell
0%
VYGR Earnings
-$0.81
$0.22
$1.24
$2.27
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 6, After Hours